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INTRODUCTION: The accuracy of perioperative evaluation methods available is better than chance, but their performance is
not ideal.
OBJECTIVES: To compare a new evaluation method (EMAPO) to the American College of Physicians method for determining
the risk of cardiovascular complications in noncardiac surgeries and to look for new influencing variables.
METHODS: Evaluations through EMAPO and the American College of Physicians method were employed for 700 patients.
Cardiac events and deaths were recorded, the risk variables related to the occurrence of complications were verified, and the
models were compared by analyzing the areas under the receiver operating characteristic curves.
RESULTS: Mortality rate was 3.4%, and the incidence of cardiovascular complications was 5.3%. Renal failure (P = 0.01), major
surgery (P = 0.004), and emergency surgery (P = 0.003) were independently related to the occurrence of cardiovascular complications.
The two methods produced similar results.
CONCLUSION: EMAPO is as good as the American College of Physicians method in determining the risk of cardiovascular
complications in noncardiac surgeries. New variables related to surgical risk were identified.
KEYWORDS: Cardiac risk. Noncardiac surgery. Algorithms. Cardiovascular complications. Risk factors.
There were 2,747,254 hospitalizations for surgical in-
terventions in Brazil in 2000. The mortality rate associated
with these hospitalizations was 2.1%, and the average pe-
riod of hospitalization was 4.6 days, generating a cost of
roughly 750 million dollars.1 In the United States, 3% to
10% of the patients undergoing surgical intervention have
some sort of complication, and of the deaths that occur in
the postoperative period, 40% have a cardiovascular cause.2
Perioperative evaluation consists of a set of medical pro-
cedures performed before, during, and after the surgery to
establish the degree of risk and to propose strategies for
reducing the incidence of cardiovascular complications.3-
26
 The existing evaluation methods are based on studies that
consider the impact of clinical and surgical characteristics
on the postoperative evolution. The currently available
evaluation methods have limitations because they leave out
certain diseases, do not adopt modern diagnostic criteria
and treatment options for others, and do not consider the
extent of the surgery or the functional capacity. The accu-
racy of these methods is better than chance, but their per-
formance is not ideal. The American College of Physicians
(ACP) method is the most widely used method internation-
ally, but it also has problems,6 eg, the wide range of dif-
ferent risk levels—particularly that of the intermediate
level—in which different patients with clearly different risk
profiles are classified in the same category.
The objectives of this study were to determine the risk
profile and the incidence of perioperative complications in
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a Brazilian population and to compare an international
evaluation method (ACP) with a new one called EMAPO
(Multicenter Study of Perioperative Evaluation), which con-
siders diseases that were not mentioned in the previous
guidelines and modern treatment options in order to deter-
mine new clinical variables associated with cardiovascu-
lar complications.
Population
After approval by the local ethics committee, all con-
secutive patients older than 15 years referred for noncardiac
surgeries, for whom perioperative evaluation was requested
in the period between February 2001 and May 2002 in 3
centers (1 university hospital and 2 private clinics: Hospi-
tal das Clínicas, São Paulo University Medical School,
Clinicor Clinic of Ribeirão Preto, and Ritmocordis Clinics
of Valinhos) were studied. Patients who did not undergo
surgery for any reason were excluded.
METHODS
The patients were evaluated through the method pro-
posed by the EMAPO Project (Multicenter Study of
Perioperative Evaluation of SOCESP – Society of Cardi-
ology of the State of São Paulo). This method proposes cal-
culating the cardiovascular risk index by adding the accu-
mulated points that correspond to the presence of risk fac-
tors described previously and new variables that were added
based on the clinical experience of the authors (Appen-
dix).5,6,27 Additionally, EMAPO proposes a new classifica-
tion, stratifying the perioperative risk into 5 levels accord-
ing to the expected complication rate (Table 1).
The same population was also evaluated using the
American College of Physicians (ACP) criteria, which
stratifies the perioperative risk into 3 levels according to
the expected complication rate.6
The patients were monitored until discharge, and car-
diac events and deaths were recorded. The cardiac events
considered were ischemic events (unstable angina and myo-
cardial infarction), embolic events, cardiac arrhythmias, and
others. Cardiac events were defined as previous reported.8
Statistical Analysis
We estimated that the sample to be studied should have
roughly 700 individuals. The risk variables were descrip-
tively analyzed, and their relationship to the occurrence of
perioperative cardiac complications was subsequently veri-
fied. Although some patients presented more than 1 com-
plication, such patients were reckoned in the same man-
ner as patients with a single complication. The chi-square
method was used for this first analysis. Multivariate analysis
was performed based on the variables identified in the
univariate model. A P value lower than or equal to 0.05
was considered statistically significant.
Both methods were then compared according to crite-
ria of sensitivity and specificity using the areas under the
receiver operating characteristic (ROC) curve.28-30
RESULTS
Seven hundred patients with a mean age of 56 years (18
to 96 years) were evaluated. The majority of these patients
were women (59.1%), and the presence of clinically de-
tectable cardiac disease was described in 52%. Regarding
the type of surgery, 95% were elective, 4% urgent, and
0.4% emergency surgery. The average hospitalization pe-
riod was 3.6 days (1 to 72 days).
The evaluation with the EMAPO method yielded a
mean score of 3.5 points (within a range of 0 to 33), and
patients with low and very low risk prevailed (83%). The
evaluation of the same sample by the ACP method resulted
in a mean score of 2.0 points (0 to 20) and the patients
with low risk (94.4%) also prevailed.
The mortality rate was 3.4%. Perioperative complica-
tions were observed in 64 patients (9.1%). There were 42
cardiovascular events in 37 patients (5.3%) as follows: 16
Table 1 - Complication risk index according to the EMAPO
Risk Status Total Score Expected Cardiac
Complications
Very low 0 < 1%
Low Up to 5 < 3%
Moderate From 6 to 10 < 7%
Elevated From 11 to 15 7% –13%
Very elevated Above 15 > 13%
EMAPO = Multicenter Study of Perioperative Evaluation
Table 2 - Risk level classification and cardiovascular
complications (CC)
EMAPO ACP
Risk Patients (%) CC (%) Patients (%) CC (%)
Very Low 370 (52.9) 11/370 (3.0) —— ——
Low 211 (30.1) 12/211 (5.7) 661 (94.4) 34/661 (5.1)
Moderate / 64 (9.1) 10/64 (15.6) 35 (5.0) 2/35 (5.7)
Intermediate
Elevated / High 37 (5.3) 1/37 (2.7) 4 (0.6) 1/4 (25.0)
Very Elevated 18 (2.6 ) 3/18 (16.7) —— ——
EMAPO = Multicenter Study of Perioperative Evaluation
ACP = American College of Physicians method
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RISK FACTORS - VARIABLES:
Minor: Scoring Points:
( ) Inactive and bedridden patient 4 points
( ) Systemic arterial hypertension with
           left ventricular hypertrophy and ST-T alteration 4 points
( ) Previous ischemic stroke (less than 3 months) 4 points
( ) Diabetes mellitus associated with nephropathy/cardiopathy or use of insulin 4 points
( ) Chronic coronary disease with negative treadmill exercise test
            (less than 3 months) 4 points
( ) Intraperitoneal, intrathoracic, aortic and its branches,
            or major orthopedic surgery 4 points
( ) Presence of asymptomatic aortic aneurism, surgery not suggested 4 points
( ) Age above 70 years 5 points
( ) Acute myocardial infarction (more than 6 months) 5 points
( ) Acute pulmonary edema secondary to congestive heart failure
            (more than a week) 5 points
( ) Chronic atrial fibrillation, paroxysmal atrial tachyarrhythmias and
            documented unsustained ventricular tachycardias 5 points
( ) Poor general medical status: ( ) K< 3.0 mEq/L or HCO2 < 20 mEq/L 5 points
( ) pO2 < 60 torr or pCO2 > 50 torr
( ) urea > 50 mg/dL or creatinine > 2.3 mg/dL
( ) elevated AST or active hepatic disease
Moderate:
( ) Acute myocardial infarction (less than 6 months) and not in the acute phase 10 points
( ) Angina pectoris currently stable 10 points
( ) Unstable angina pectoris episode (less than 3 months), currently absent 10 points
( ) Acute pulmonary edema secondary to congestive heart failure
           (less than a week) 10 points
( ) Sustained supraventricular tachyarrhythmias with elevated ventricular response
        Documented sustained repetitive ventricular arrhythmia / history of ventricular
            fibrillation / Aborted sudden death episode (more than 3 months) /
            Carrier of implantable automatic defibrillator 10 points
( ) Canadian Cardiovascular Society Angina classification – class III 10 points
( ) Emergency surgery 10 points
( ) Transplant surgery. Vital organ recipient: kidney and liver 10 points
( ) Severe mitral stenosis 10 points
Major:
( ) Canadian Cardiovascular Society Angina classification – class IV 20 points
( ) Critical aortic stenosis 20 points
( ) Congestive heart failure class IV 20 points
( ) Acute myocardial infarction (acute phase) 20 points
( ) Recent episode of ventricular fibrillation or aborted sudden death
            in noncarrier of implantable automatic defibrillator 20 points
( ) Transplant surgery. Vital organ recipient: lung 20 points
EMAPO = Multicenter Study of Perioperative Evaluation
Figure 1 - Risk factors for perioperative complications and respective points in the EMAPO project
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ischemic, 10 arrhythmic, 6 embolic, 2 congestive, and 8
nonspecified cardiovascular etiologies. Among the patients
that presented complications, 37.5% died (Table 2).
The significance of the variables used in the EMAPO
questionnaire regarding the existence of cardiac complica-
tions during the perioperative period was determined. In the
univariate analysis, the statistically significant variables were
detectable cardiopathy, poor general medical status (Figure
1), urea > 50 mg/dL or creatinine > 2.3 mg/dL, emergency
surgery, major surgery, surgery duration > 4 hours, blood loss
> 1000 mL, hospitalization > 3 days, chronic coronary dis-
ease with negative noninvasive stress testing (less than 3
months), male gender, general anesthesia, myocardial inf-
arction < 6 months, aortic aneurism, and age > 70 years. In
the multivariate analysis, the variables related to renal fail-
ure (P = 0.016), major surgery (P = 0.004), and emergency
surgery (P = 0.03) remained significant.
The ROC curves derived from patient data according
to EMAPO and ACP methods were analyzed. In order for
the two methods to be compared, the 5 levels of the
EMAPO method were grouped in 3 categories: very low
and low risks were compared with the ACP low risk; mod-
erate was compared with the ACP intermediate risk; el-
evated and very elevated were compared with the ACP high
risk. The ROC curves are represented in Figure 2.
The comparison of the two methods showed that the ar-
eas did not differ and there was no significant difference
between them in predicting the occurrence of cardiovas-
cular complications. Besides that, new variables related to
surgical risk were identified, such as male gender, aortic
aneurysm and major surgery.
DISCUSSION
The majority of patients in our study was classified
within the low risk group for perioperative cardiovascular
complications. Nevertheless, we observed a high overall
incidence of perioperative cardiovascular complications
(5.3%). The accuracy of perioperative evaluation methods
available today is low, limiting our ability to take meas-
ures that would reduce cardiovascular complications.
Gilbert et al compared the perioperative evaluation meth-
ods used in clinical practice in 2035 patients. These meth-
ods were the ACP, the American Society of
Anesthesiologists Index (ASA), the Canadian Cardiovas-
cular Society Index, and the Goldman Index. In this popu-
lation, 30% of the patients underwent low risk surgeries
(ophthalmologic, superficial, and endoscopic), and cardiac
complications occurred in 6.4% of patients. By comparing
the accuracy of the methods using the ROC curve analy-
sis, the authors concluded that all of them have limited ac-
curacy and no method was better than the others. The au-
thors suggest that more efficient methods are needed to pre-
vent the occurrence of perioperative cardiovascular com-
plications and that other clinical variables should be con-
sidered during the evaluation of risk.31 Consequently, we
tried to create a new score to predict cardiac complications.
Existing methods of perioperative evaluation were de-
veloped by choosing variables previously described in the
literature as predictors of perioperative events and giving
points in order to create a score. The EMAPO was designed
by updating variable definitions and adding new ones based
on clinical experience, and it was as good as the ACP
method in predicting cardiac events. Additionally, in the
EMAPO model, major surgery was significant as a predic-
tor of cardiac complications; this variable is not consid-
ered in the ACP model.
The intermediate risk of the ACP model includes pa-
tients with a wide risk range (chance of cardiac complica-
tions between 3% and 15%). By proposing an extra 2 risk
levels for cardiovascular complications, the EMAPO
method intended to split the two most important strata, low
risk and high risk, into 2 groups to disclose the differences
in these very heterogeneous groups. However, this strategy
failed, since no increased risk levels were identified, prob-
ably because of the relatively small number of patients in
each group. Although the efficacy of EMAPO is similar to
that of ACP, the execution of the former is more complex
because of the number of items and consequently the
amount of information needed. Besides that, as this is a
new score, there are no guidelines regarding the strategy
to be taken in order to minimize the cardiac risk for each
category of patients.
Figure 2 - ROC (receiver operating characteristic) curves according to the
results from EMAPO and ACP evaluations
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As the cost of hospital expenditures increases, the re-
duction of perioperative complication incidence becomes
mandatory, because complications often result in a longer
hospitalization period and in subsidiary exams and other
medical interventions.3,7,8,32
More studies are needed to improve our ability to de-
termine which patient has more cardiac risk after
noncardiac surgery. The division of the intermediate risk
into a more narrow risk range may be the first stage in this
direction.
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RESUMO
Pinho C, Grandini PC, Gualandro DM, Calderaro D,
Monachini M, Caramelli B. Estudo multicêntrico de ava-
liação perioperatória para operações não cardíacas
(EMAPO). Clinics. 2007;62(1):17-22.
INTRODUÇÃO: A precisão dos métodos de avaliação
perioperatória disponíveis é melhor que o acaso, porém está
longe do ideal.
OBJETIVOS: Comparar um novo método de avaliação
perioperatória (EMAPO) ao método do American College
of Physicians para determinar o risco cardíaco em cirurgi-
as não cardíacas e buscar novas variáveis envolvidas na de-
terminação deste risco.
MÉTODOS: O EMAPO e o método do American College
of Physicians foram aplicados em 700 pacientes. A ocor-
rência de eventos cardíacos e de mortes foi documentada,
a relação entre as variáveis de risco e as complicações foi
estabelecida e os métodos foram comparados analisando
as áreas sob a curva ROC.
RESULTADOS: A mortalidade foi 3.4% e a incidência de
complicações cardiovasculares 5.3%. A presença de insu-
ficiência renal (p=0.01), cirurgia de grande porte (p=0.004)
e cirurgia de emergência (p=0.003) se correlacionaram com
a ocorrência de complicações cardiovasculares na análise
multivariada. Não houve diferença entre os dois métodos.
CONCLUSÕES: O EMAPO é tão eficaz quanto o méto-
do do American College of Physicians para determinar o
risco de complicações cardiovasculares em cirurgias não
cardíacas. Novas variáveis relacionadas com o risco
perioperatório foram encontradas.
UNITERMOS: Avaliação perioperatória. Risco cardíaco.
Algorítimos. Fatores de risco. Complicações cardio-
vasculares.
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